GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Broncus Holding Corp (HKSE:02216) » Definitions » PS Ratio

Broncus Holding (HKSE:02216) PS Ratio : 18.99 (As of Apr. 25, 2025)


View and export this data going back to 2021. Start your Free Trial

What is Broncus Holding PS Ratio?

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Broncus Holding's share price is HK$2.45. Broncus Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.13. Hence, Broncus Holding's PS Ratio for today is 18.99.

Warning Sign:

Broncus Holding Corp stock PS Ratio (=6.46) is close to 1-year high of 6.71.

The historical rank and industry rank for Broncus Holding's PS Ratio or its related term are showing as below:

HKSE:02216' s PS Ratio Range Over the Past 10 Years
Min: 2.8   Med: 6.71   Max: 312.5
Current: 19

During the past 6 years, Broncus Holding's highest PS Ratio was 312.50. The lowest was 2.80. And the median was 6.71.

HKSE:02216's PS Ratio is ranked worse than
93.03% of 803 companies
in the Medical Devices & Instruments industry
Industry Median: 3.07 vs HKSE:02216: 19.00

Broncus Holding's Revenue per Sharefor the six months ended in Jun. 2024 was HK$0.06. Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.13.

Warning Sign:

Broncus Holding Corp revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Broncus Holding was -24.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 50.60% per year.

During the past 6 years, Broncus Holding's highest 3-Year average Revenue per Share Growth Rate was 50.60% per year. The lowest was 7.70% per year. And the median was 29.15% per year.

Back to Basics: PS Ratio


Broncus Holding PS Ratio Historical Data

The historical data trend for Broncus Holding's PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Broncus Holding PS Ratio Chart

Broncus Holding Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
PS Ratio
Get a 7-Day Free Trial - 31.34 15.27 4.82 4.57

Broncus Holding Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 15.27 - 4.82 - -

Competitive Comparison of Broncus Holding's PS Ratio

For the Medical Devices subindustry, Broncus Holding's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Broncus Holding's PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Broncus Holding's PS Ratio distribution charts can be found below:

* The bar in red indicates where Broncus Holding's PS Ratio falls into.


;
;

Broncus Holding PS Ratio Calculation

The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.

Broncus Holding's PS Ratio for today is calculated as

PS Ratio=Share Price/Revenue per Share (TTM)
=2.45/0.129
=18.99

Broncus Holding's Share Price of today is HK$2.45.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Broncus Holding's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was HK$0.13.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PS Ratio=Market Cap/Revenue

The Revenue here is for the trailing 12 months.


Broncus Holding  (HKSE:02216) PS Ratio Explanation

The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.

When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.

Similar to the PE Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PS Ratio measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.


Broncus Holding PS Ratio Related Terms

Thank you for viewing the detailed overview of Broncus Holding's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Broncus Holding Business Description

Traded in Other Exchanges
N/A
Address
No. 88 Jiangling Road, Xixing Street, Room 801, 8th Floor, Building 8, Binjiang District, Hangzhou, CHN
Broncus Holding Corp is a medical device company focused on the development of interventional pulmonology products. It is engaged in the field of interventional pulmonology, providing lung solutions in China and globally. The integrated interventional pulmonology platform addresses the pain points of the existing diagnosis and treatment paradigms and unmet medical needs for lung diseases by improving the diagnosis and treatment effects of lung cancer and COPD. The company offers products like Archimedes System, LungPoint, BioStar, FleXNeedle Biopsy Needle, RF-II, and InterVapor System among others. Geographically, the company derives a majority of its revenue from the Chinese Mainland, and the rest from European Union, USA, and other regions.
Executives
Xu Hong 2101 Beneficial owner
Zi Zhenjun
Xin Nuo Tong Investment Limited 2201 Interest of corporation controlled by you
Qiming Corporate Gp Iv, Ltd. 2201 Interest of corporation controlled by you
Qiming Venture Partners Iv, L.p. 2101 Beneficial owner
Qiming Gp Iv, L.p. 2201 Interest of corporation controlled by you
Qm12 Limited 2101 Beneficial owner
Dinova Capital Limited
Dinova Venture Partners Gp Iii, L.p.
Broncus Biomedical Limited
Dinova Healthcare Gamma Fund (usd) L.p.
Computershare Hong Kong Trustees Limited 2301 Trustee
Dinova Healthcare (hong Kong) Co., Limited
Lake Bleu Capital (hong Kong) Limited 2102 Investment manager
Hang Zhou De Nuo Shang Wu Zi Xun Zi Xun You Xian Gong Si

Broncus Holding Headlines

No Headlines